MedPath

Effect of a Nursing Program for Patients With Cystic Fibrosis on Disease Management

Not Applicable
Completed
Conditions
Cystic Fibrosis
Interventions
Other: CF Nursing Program
Registration Number
NCT02286050
Lead Sponsor
University of Zurich
Brief Summary

The purpose of this study is to evaluate the effect of a nursing program in patients with cystic fibrosis.

Detailed Description

All patients living with cystic fibrosis will be asked by questionnaire before (November 2014) and after (September 2016) the implementation of the program about their satisfaction with treatment, trust in the CF-Team, adherence, self-efficacy, treatment burden and quality of life.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Cystic Fibrosis
Read More
Exclusion Criteria
  • None
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
CF Nursing InterventionCF Nursing Program-
Primary Outcome Measures
NameTimeMethod
Difference between baseline patient satisfaction and month 22month 22

Self-reported patient satisfaction will be measured with a newly developped questionnaire.

Secondary Outcome Measures
NameTimeMethod
Difference between baseline self-efficacy and month 22month 22

Self-reported self-efficacy to master the the therapeutic regimen will be measured with a newly developped questionnaire.

Difference between baseline adherence and month 22month 22

Self-reported adherence to therapy will be measured with the Medication Adherence Report Scale (MARS) and a newly developped questionnaire.

Difference between baseline treatment burden and month 22month 22

Self-reported treatment burden will be measured wiht a subscale of the CFQ-R.

Difference between baseline trust and month 22month 22

Self-reported trust will be measured with the short version of the Wake Forest Trust Scale.

Difference between baseline information need and month 22month 22

Information needs will be assessed with a subscale of the PICKER-questionnaire for patients with CF.

Trial Locations

Locations (1)

University Hospital Zurich

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath